Lv1
70 积分 2024-09-06 加入
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study
22天前
已完结
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study
22天前
已完结
Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects
2个月前
已完结
Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target
2个月前
已完结
Telitacicept: First Approval
2个月前
已完结
Epidemiology and management of uterine fibroids
3个月前
已完结
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
4个月前
已完结
伴有和不伴有快速动眼睡眠行为障碍的帕金森病症状的纵向变化：牛津发现队列研究
8个月前
已完结
皖公网安备34019202002308
